Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Health Care M&A Weekly Deals, The Week Ending November 24, 2017
We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Long-Term Care Acquirer Target Price CA Senior Living LLC 3 assisted living communities N/A Pharmaceuticals Acquirer Target Price Kwangdong Pharmaceutical Co., Ltd. License to bremelanotide... Read More »
Dermatology Practice Deals Up 46% in 2017
Acquisitions of dermatology practices are surging in 2017. Through mid-November, we’ve counted 37 transactions for these physician practices, up nearly 46% compared with all of 2016 (26 announced transactions), according to our Deal Search Online database. As we’ve noted before, private equity play a significant role in the increased deal count. Epiphany Dermatology, a portfolio company of CI Capital Partners, has been the busiest acquirer this year, with eight transactions concentrated in Arizona, New Mexico, Oklahoma and Texas. All had three or fewer physicians, and none of the deals disclosed prices. Two privately held companies have announced five transactions apiece in... Read More »
Stat of the Week: 0% Growth in Q3 Pharma Deals
“Sluggish” is the best word to describe deal activity in the Pharmaceutical sector this year. Mergers and acquisitions have dropped every quarter since the third quarter of 2016. In Q3:17, this dearth of deals may have finally bottomed out. Deal making stayed even with the previous quarter, but that total represented the nadir for deal volume in the previous 12 months. At 16 deals, Q3:17 transactions made up 17% of the 94 deals announced in the past 12 months. The total is 59% lower than in the same quarter in 2016. As we noted in last quarter’s edition, the global pharmaceutical companies are waiting to see the outcome of President Trump’s tax reform efforts. They are in no... Read More »
Physician Practice Deals Down 15% in Q3:17
Physician medical groups are still hot properties, of course. But the rate of consolidation within the industry accelerated rapidly in the past two years, and it was inevitable the pace would slacken at some point. The 28 acquisitions announced in the third quarter represent 19% of the 145 deals announced in the previous 12 months. Deal volume was down 10% compared with the previous quarter, and down 15% versus the same quarter a year earlier. Longer payment cycles associated with value-based reimbursement is just one reason many physician practices have joined larger groups or health systems. Electronic medical records, revenue cycle management and billing are all necessities for today’s... Read More »
Stat of the Week: Managed Care Deals Up 50% in Q3:17
Deal volume in this sector was low in 2016, and through the first half of 2017. Then deal activity doubled in the third quarter, if only to eight transactions. Third quarter deal volume represents a 40% share of the 20 deals announced in the previous 12 months, and a 167% increase over the same quarter in 2016. We don’t expect this sector to sustain even this level of activity, given recent events. Although the Republican party has control of Congress and the White House, efforts to repeal the Affordable Care Act were unsuccessful, even in a late September push. President Trump made clear his disappointment, and then issued a pair of executive orders on October 12 aimed directly at the... Read More »Health Care M&A Weekly Deals, The Week Ending November 17, 2017
We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Biotechnology Acquirer Target Price Janssen Biotech Inc. License to 6 bispecific antibodies $50 million ITUS Corporation License to CAR-T technology N/A Excision Biotherapeutics License to CRISPR gene editors N/A Monopar Therapeutics, Inc.... Read More »
Merit Medical Scores Assets from BD and Bard
Just after the release of the third quarter results, Merit Medical Systems, Inc. (NASDAQ: MMSI) announced an asset purchase agreement with two of its competitors. Merit has made two other similar acquisitions in 2017. The company entered into an asset purchase agreement with Becton, Dickinson and Company (NYSE: BDX) and C.R. Bard, Inc. (NYSE: BCR) to acquire various assets in relation to BD’s $24 billion acquisition of C.R. Bard, announced on April 23, 2017. The acquired assets include soft tissue core needle biopsy products currently sold by BD under the trade names of Achieve™ Programmable Automatic Biopsy System, Temno™ Biopsy System and Tru-Cut™ Biopsy Needles, which are currently sold... Read More »Deal of the Week: Almost Family/LHC Group
The Home Health & Hospice sector is gearing up for a busy 2018, compared with the sluggish performance turned so far in 2017. Two leading companies, LHC Group (NASDAQ: LHCG) and Almost Family (NASDAQ: AFAM) announced a “merger of equals” on November 16. That transaction followed third-quarter earnings calls from Amedysis (NASDAQ: AMED) and Brookdale Senior Living (NYSE: BKD) with each CEO discussing aggressive moves into the hospice sector. Bring it on! M&A activity in the Home Health & Hospice sector has been slow, to say the least, throughout 2017. Prior to the LHC/Almost Family announcement, just 41 deals were reported through mid-November, with a meager $20.9 million in... Read More »
Cardinal Health Sheds its China Operations
Cardinal Health Inc. (NYSE: CAH) put its Cardinal Health China business up for sale in July of this year, following concerns that upcoming drug distribution reform could threaten the company’s growth. Cardinal’s China business is the eighth largest drug distributor in the country, operating 14 direct sales units and 17 distribution centers that cover 322 cities and 11,000 medical institutions. The bidding process was very competitive, according to Reuters, and names like Warburg Pincus were rumored to have competed in the final rounds, among other private equity and Chinese pharmaceutical bidders. On November 14th, Cardinal Health announced that Shanghai Pharmaceuticals Holding Co., Ltd.... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
